PHARMACOKINETICS, RELATIVE BIOAVAILABILITY AND FOOD EFFECT OF JZP-258 AND SODIUM OXYBATE: RESULTS OF TWO PHASE 1, OPEN-LABEL, RANDOMISED CROSSOVER STUDIES IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Chen, C. [1 ]
Skowronski, R. [1 ]
Jenkins, J. [1 ]
Zomorodi, K. [1 ]
机构：
[1] Jazz Pharmaceut, Palo Alto, CA USA
来源：
SLEEP MEDICINE | 2019年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics, bioavailability, and bioequivalence of lower-sodium oxybate in healthy participants in two open-label, randomized, crossover studies
    Chen, Cuiping
    Jenkins, Jack
    Zomorodi, Katie
    Skowronski, Roman
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2278 - 2287
  • [2] Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
    Preskorn, Sheldon
    Ereshefsky, Larry
    Chiu, Yu-Yuan
    Poola, Nagaraju
    Loebel, Antony
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (05) : 495 - 505
  • [3] Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers
    Bogan, Richard
    Thorpy, Michael J.
    Winkelman, John W.
    Dubow, Jordan
    Gudeman, Jennifer
    Seiden, David
    SLEEP MEDICINE, 2022, 100 : 442 - 447
  • [4] A Randomized, Open-Label, Crossover Study Evaluating the Effect of Food on the Relative Bioavailability of Linagliptin in Healthy Subjects
    Graefe-Mody, Ulrike
    Giessmann, Thomas
    Ring, Arne
    Iovino, Mario
    Woerle, Hans-Juergen
    CLINICAL THERAPEUTICS, 2011, 33 (08) : 1096 - 1103
  • [5] Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
    deVries, Tina
    Dentiste, Angela
    Handiwala, Lata
    Jacobs, David
    NEUROLOGY AND THERAPY, 2019, 8 (02) : 449 - 460
  • [6] Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
    Tina deVries
    Angela Dentiste
    Lata Handiwala
    David Jacobs
    Neurology and Therapy, 2019, 8 : 449 - 460
  • [7] A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food
    Zomorodi, Katie
    Kankam, Martin
    Lu, Yuan
    CLINICAL THERAPEUTICS, 2019, 41 (02) : 196 - 204
  • [8] The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants
    Patel, Maulik
    Chen, Joseph
    McGrory, Stephanie
    O'Gorman, Melissa
    Nepal, Sunil
    Ginman, Katherine
    Pithavala, Yazdi K.
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 131 - 139
  • [9] The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants
    Maulik Patel
    Joseph Chen
    Stephanie McGrory
    Melissa O’Gorman
    Sunil Nepal
    Katherine Ginman
    Yazdi K. Pithavala
    Investigational New Drugs, 2020, 38 : 131 - 139
  • [10] Relative Bioavailability and Food Effect Evaluation for 2 Tablet Formulations of Asciminib in a 2-Arm, Crossover, Randomized, Open-Label Study in Healthy Volunteers
    Menssen, Hans D.
    Quinlan, Michelle
    Kemp, Charisse
    Tian, Xianbin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (03): : 385 - 394
12345